{"DataElement":{"publicId":"7653186","version":"1","preferredName":"Surgical Margins Assessment Soft Tissue Sarcoma Status","preferredDefinition":"A status to indicate whether the presence of actual or potential neoplastic tissue has been left outside the boundary of a resected specimen of the muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","longName":"7642156v1.0:7653185v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7642156","version":"1","preferredName":"Surgical Margins Status Assessment","preferredDefinition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient._The final result of a determination of the value, significance, or extent of.","longName":"7642154v1.0:2465182v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7642154","version":"1","preferredName":"Surgical Margins Status","preferredDefinition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","longName":"C123560","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Margins Status","conceptCode":"C123560","definition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E1EAB3-3ED4-6E7C-E053-4EBD850ADE2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E1EAB3-3EE2-6E7C-E053-4EBD850ADE2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":null,"administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7653185","version":"1","preferredName":"Soft Tissue Sarcoma Status","preferredDefinition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._A condition or state at a particular time.","longName":"7653185v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Margins uninvolved by sarcoma","valueDescription":"Margin Uninvolved by Sarcoma","ValueMeaning":{"publicId":"7653276","version":"1","preferredName":"Margin Uninvolved by Sarcoma","longName":"7653276","preferredDefinition":"The margin of the sample has no sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Uninvolved by Sarcoma","conceptCode":"C159235","definition":"The margin of the sample has no sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2107AC6-1772-68C4-E053-4EBD850A7383","latestVersionIndicator":"Yes","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"ONEDATA","dateModified":"2021-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2107AC6-1809-68C4-E053-4EBD850A7383","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"ONEDATA","dateModified":"2021-05-11","deletedIndicator":"No"},{"value":"Margin(s) involved by sarcoma","valueDescription":"Margin Involved by Sarcoma","ValueMeaning":{"publicId":"7653279","version":"1","preferredName":"Margin Involved by Sarcoma","longName":"7653279","preferredDefinition":"The margin of the sample has sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Involved by Sarcoma","conceptCode":"C159233","definition":"The margin of the sample has sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2107AC6-179B-68C4-E053-4EBD850A7383","latestVersionIndicator":"Yes","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"ONEDATA","dateModified":"2021-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2107AC6-17F5-68C4-E053-4EBD850A7383","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"ONEDATA","dateModified":"2021-05-11","deletedIndicator":"No"},{"value":"Cannot be assessed","valueDescription":"Margin Status Cannot be Assessed","ValueMeaning":{"publicId":"7642164","version":"1","preferredName":"Margin Status Cannot be Assessed","longName":"7642164","preferredDefinition":"A result that the margin status cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Status Cannot be Assessed","conceptCode":"C160705","definition":"A result that the margin status cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E20D99-4F2D-2874-E053-4EBD850ACE1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C222F152-7C4A-6709-E053-4EBD850A1E43","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7653184","version":"1","preferredName":"Soft Tissue Sarcoma Status","preferredDefinition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.:A condition or state at a particular time.","longName":"C9306:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C20D0A25-9C98-16D9-E053-4EBD850A2F16","latestVersionIndicator":"Yes","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"ONEDATA","dateModified":"2021-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Historical","id":"C20D0A25-9CA9-16D9-E053-4EBD850A2F16","latestVersionIndicator":"Yes","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":null,"administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218984","version":"1","longName":"Soft Tissue","context":"OCCPR"},{"publicId":"7634335","version":"1","longName":"SAR Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Margin Status","type":"Preferred Question Text","description":"Margin Status","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C21064A6-0E67-4491-E053-4EBD850A405F","latestVersionIndicator":"Yes","beginDate":"2021-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-11","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":"6/22/21 jk upd sys gen def. 5/4/21 ls created for SAR CRF.","administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}